The addition of the antisense agent oblimersen to fludarabine and cyclophosphamide improved response to therapy and survival in patients with relapsed or refractory chronic lymphocytic leukemia. Medscape Medical News
Uninsured patients and those covered by Medicaid are far more likely to present with advanced-stage cancer at diagnosis than those with private coverage. Medscape Medical News
Bevacizumab has shown significant single-agent activity in relapsed ovarian cancer in 2 phase 2 trials, prompting further studies of this disease. Medscape Medical News
Might an equivocal HER2 amplification result from a breast core biopsy specimen be consistently representative of the HER2 status of the overall breast tumor? What are the testing implications? American Journal of Clinical Pathology
Does tumor vascularity, or expression of vascular endothelial growth factor protein and its receptors, contribute to patient outcomes? Laboratory Investigation
